U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07815691) titled 'Endocannabinoids in Reward' on Sept. 03.
Brief Summary: This study will examine sex differences in the effects of cannabis in people that regularly use it. Men and women that use cannabis at least 4 days a week will participate in a study involving 3 in-person visits. The first visit will be used to determine eligibility for the study. The other two visits will last 7 hours each and take place at least two days apart. Visits include administration of either THC, the chemical responsible for many of the psychoactive effects of cannabis, or a placebo; completion of questionnaires; and a 1-hour brain scan. One visit will also include ...